Metagenomic and culturomic analysis of gut microbiota dysbiosis during Clostridium difficile infection-Reference-Cited by-同舟云学术

Metagenomic and culturomic analysis of gut microbiota dysbiosis during Clostridium difficile infection

Published:2019-09-05 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Amrane Sophie,Hocquart Marie,Afouda Pamela,Kuete Edmond,Pham Thi-Phuong-Thao,Dione Niokhor,Ngom Issa Isaac,Valles Camille,Bachar Dipankar,Raoult Didier,Lagier Jean Christophe

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-49189-8.pdf

Reference51 articles.

1. Debast, S. B., Bauer, M. P. & Kuijper, E. J. European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection. Clin. Microbiol. Infect. 20, 1–26 (2014).

2. Lessa, F. C. et al. Burden of Clostridium difficile Infection in the United States. N. Engl. J. Med. 372, 825–834 (2015).

3. Vincent, C. et al. Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection. Microbiome 1, 18 (2013).

4. Seekatz, A. M., Rao, K., Santhosh, K. & Young, V. B. Dynamics of the fecal microbiome in patients with recurrent and nonrecurrent Clostridium difficile infection. Genome Med. 8, 47 (2016).

5. van Nood, E. et al. Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile. N. Engl. J. Med. 368, 407–415 (2013).

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut Microbiota Composition and Clostridioides Difficile Infection: The Potential Protective Role of Faecalibacterium Prausnitzii;Gut Microbes Reports;2024-09-05

2. Gut microbiome and plasma lipidome analysis reveals a specific impact of Clostridioides difficile infection on intestinal bacterial communities and sterol metabolism;mBio;2024-08-27

3. Rational Design of Live Biotherapeutic Products for the Prevention ofClostridioides difficileInfection;2024-05-02

4. Gut Microbiota Associated with Clostridioides difficile Carriage in Three Clinical Groups (Inflammatory Bowel Disease, C. difficile Infection and Healthcare Workers) in Hospital Field;Microorganisms;2023-10-10

5. Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection;Gut Microbes;2023-07-19